Steven Tessier

Dr. Steven Tessier


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
STSteven Tessier
Steven Tessier
RHRong He
Rong He
PGPatricia Greipp
Patricia Greipp
DVDavid Viswanatha
David Viswanatha
KBKurt Bessonen
Kurt Bessonen
AAAref Al-Kali
Aref Al-Kali

19 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
NSNeha Seth
Neha Seth
Jithma AbeykoonJithma Abeykoon
Jithma Abeykoon
GGGaurav Goyal
Gaurav Goyal
RGRonald S. Go
Ronald S. Go
STSteven Tessier
Steven Tessier
ARAishwarya Ravindran
Aishwarya Ravindran
Mesenchymal dendritic cell neoplasms represent a distinct category of hematologic malignancies that challenge traditional classifications of histiocytic and classical dendritic/Langerhans cell neoplasms. Historically grouped under the broader umbrella of dendritic cell neoplasms, these entities differ significantly in their ontogeny, histopathologic features, molecular alterations, and clinical behavior. They are categorized into three main subtypes including follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, and EBV-positive inflammatory follicular dendritic cell sarcoma/fibroblastic reticular cell tumor. They originate from mesenchymal stromal cells, and genetic alterations activating the NF- κβ pathway are frequent in follicular dendritic cell sarcomas. Immunophenotypic characterization is critical to distinguish these from other hematologic malignancies including histiocytic and classical dendritic/Langerhans cell neoplasms and other solid (non-hematopoietic) cancers. This review recapitulates current knowledge on existing classifications, details their diverse ontogeny from classical dendritic cell neoplasms, and provides insights into their clinicopathologic characteristics to improve diagnostic accuracy. We detail two case studies that demonstrate the challenges involved in the histopathologic diagnosis of these rare tumors, necessitating a comprehensive workup. Integrating developmental biology into practical diagnostic algorithms is essential to improve recognition and classification of these underdiagnosed neoplasms, ultimately guiding timely management.

11 January 2022 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
STSteven Tessier
Steven Tessier
SLSanto Longo
Santo Longo

20 May 2026 in Blood Advances
Verified
Journal Article
Open access
GRGordon J Ruan
Gordon J Ruan
STSteven Tessier
Steven Tessier
ARAishwarya Ravindran
Aishwarya Ravindran
UPUbenthira Patgunarajah
Ubenthira Patgunarajah
DPDavid L Pottinger
David L Pottinger
Jithma AbeykoonJithma Abeykoon
Jithma Abeykoon